MoonLake Immunotherapeuti...

NASDAQ: MLTX · Real-Time Price · USD
55.09
0.70 (1.29%)
At close: Aug 18, 2025, 10:44 AM

MoonLake Immunotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
180.43M 451.17M 39.51M 8.04M
Short-Term Investments
267.6M 59.84M 32.61M n/a
Long-Term Investments
n/a n/a n/a 115.04M
Other Long-Term Assets
n/a 8.42M -0.00 -115.04M
Receivables
2.84M 1.06M 217.13K 148.77K
Inventory
n/a n/a n/a 1.32M
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
474.29M 514.17M 76.51M 9.64M
Property-Plant & Equipment
3.64M 3.95M 331.97K 45.74K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.64M 12.37M 331.97K 45.74K
Total Assets
477.93M 526.54M 76.84M 9.68M
Account Payables
8.68M n/a 47.48K 1.23M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a 15M
Other Current Liabilities
-8.77M 259.73K 109.83K 1.3M
Total Current Liabilities
22.46M 9.97M 7.67M 21.09M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
620.68K 583.42K 282.21K 239.86K
Total Long-Term Liabilities
2.08M 3.08M 411.16K 239.86K
Total Liabilities
24.54M 13.05M 8.08M 21.33M
Total Debt
2.83M 3.81M 282.58K 15M
Common Stock
6.39K 6.3K 5.27K 38.54K
Retained Earnings
-235.59M -116.66M -80.65M -53.64M
Comprehensive Income
5M 2.36M 350.95K -168.18K
Shareholders Equity
446.82M 495.68M 48.9M -11.65M
Total Investments
267.6M 59.84M 32.61M 115.04M